News

Reports

Notices

News

Number Title Author Date
Notice
Alteogen announces amendment to license agreement with MSD.
alteogen | 2024.02.24 | Votes 0 | Views 847
alteogen 2024.02.24
Notice
Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile
alteogen | 2023.09.06 | Votes 0 | Views 1488
alteogen 2023.09.06
Notice
Hyaluronidase : A new way to be excluded from drug price negotiations under IRA
alteogen | 2023.08.01 | Votes 0 | Views 1671
alteogen 2023.08.01
Notice
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products
alteogen | 2023.01.06 | Votes 0 | Views 3497
alteogen 2023.01.06
Notice
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
alteogen | 2023.01.06 | Votes 0 | Views 2153
alteogen 2023.01.06
Notice
Alteogen Enters Into an Exclusive License Agreement With Intas to Develop and Commercialize Two Products
alteogen | 2023.01.06 | Votes 0 | Views 1916
alteogen 2023.01.06
Notice
Alteogen Enters into a Global License Agreement with a Top Ten Pharmaceutical Company for Use of Its Hybrozyme™ Technology
alteogen | 2023.01.06 | Votes 0 | Views 1952
alteogen 2023.01.06
Notice
Alteogen Enters into a Non-exclusive License Agreement with a Global Pharmaceutical Company for Use of Its Hybrozyme™Technology
alteogen | 2023.01.06 | Votes 0 | Views 1680
alteogen 2023.01.06
19
Alteogen and Lynkogen Enter into an Exclusive Option Agreement
alteogen | 2018.07.04 | Votes 0 | Views 2289
alteogen 2018.07.04
18
18 January 2018 Bio & Medicine Alteogen to seek US approval for clinical trials of Eylea biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 2546
alteogen 2018.05.28
17
23 Aug. 2017 Alteogen set to start phase I trial of ADC product in Korea
alteogen | 2018.05.28 | Votes 0 | Views 1637
alteogen 2018.05.28
16
26 APR 2017 Alteogen partners with Cristalia to develop long-acting growth hormone
alteogen | 2018.05.28 | Votes 0 | Views 1634
alteogen 2018.05.28
15
20 APR 2017 Alteogen to enter late-stage study of Herceptin biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 1471
alteogen 2018.05.28
14
29 MAR 2017 Korean firm to transfer biosimilar tech to Chinese partner
alteogen | 2018.05.28 | Votes 0 | Views 1500
alteogen 2018.05.28
13
29 DEC 2016 Alteogen patents
alteogen | 2018.05.28 | Votes 0 | Views 1443
alteogen 2018.05.28
12
22 DEC 2016 Alteogen clears phase 1 trial of Herceptin biosimilar in Canada
alteogen | 2018.05.28 | Votes 0 | Views 1557
alteogen 2018.05.28
11
7 Oct 2016 Alteogen receives patent in Japan
alteogen | 2018.05.28 | Votes 0 | Views 1466
alteogen 2018.05.28
10
7 Mar 2016 Additional N-glycosylation in the N-terminal region of recombinant human alpha-1 antitrypsin enhances the circulator
alteogen | 2018.05.28 | Votes 0 | Views 1326
alteogen 2018.05.28